Atara Biotherapeutics, Inc.
ATRA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001604464
In the last 90 days, Atara Biotherapeutics, Inc. insiders filed 1 open-market purchase and 1 sale; 36 institutions reported holding it in 13F filings for Q2 2026, worth $51.3M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Atara Biotherapeutics, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 43
- +8 vs. Q3 2024
- Shares held
- 2.37M
- −46.2K (−1.9%) vs. Q3 2024
- Total value
- $31.5M
- +$11.9M (+60.6%) vs. Q3 2024
- New holders
- 11
- 13 more added
- Sold out
- 3
- 11 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ATRA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 36 | $51.3M |
| Q1 2026 | 33 | $12.1M |
| Q4 2025 | 41 | $37.1M |
| Q3 2025 | 37 | $27.0M |
| Q2 2025 | 32 | $13.9M |
| Q1 2025 | 37 | $12.4M |
| Q4 2024 | 43 | $31.5M |
| Q3 2024 | 35 | $19.6M |
| Q2 2024 | 48 | $24.1M |
| Q1 2024 | 82 | $57.8M |
| Q4 2023 | 91 | $33.2M |
| Q3 2023 | 109 | $130.5M |
| Q2 2023 | 118 | $145.8M |
| Q1 2023 | 125 | $297.8M |
| Q4 2022 | 139 | $319.3M |
| Q3 2022 | 155 | $376.2M |
| Q2 2022 | 134 | $777.4M |
| Q1 2022 | 145 | $909.5M |
| Q4 2021 | 139 | $1.50B |
| Q3 2021 | 140 | $1.61B |
| Q2 2021 | 145 | $1.34B |
| Q1 2021 | 151 | $1.24B |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Atara Biotherapeutics, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citigroup Inc | 2 | $27 | 0.00% | −6−75.0% | Reduced |
| Alexis Investment Partners, LLC | 28 | $373 | 0.00% | +28 | New |
| EverSource Wealth Advisors, LLC | 35 | $466 | 0.00% | 00.0% | Unchanged |
| GAMMA Investing LLC | 56 | $745 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 61 | $812 | 0.00% | +5+8.9% | Added |
| Point72 (DIFC) Ltd | 68 | $905 | 0.00% | +68 | New |
| Tower Research Capital LLC (TRC) | 70 | $932 | 0.00% | −682−90.7% | Reduced |
| Royal Bank of Canada | 83 | $1.00K | 0.00% | +66+388.2% | Added |
| Rhumbline Advisers | 175 | $2.33K | 0.00% | 00.0% | Unchanged |
| Banque Transatlantique SA | 176 | $2.33K | 0.00% | +176 | New |
| IFP Advisors, Inc | 180 | $2.40K | 0.00% | 00.0% | Unchanged |
| Jones Financial Companies LLLP | 203 | $2.70K | 0.00% | +203 | New |
| JPMorgan Chase & Co | 216 | $2.88K | 0.00% | −1,154−84.2% | Reduced |
| R Squared Ltd | 240 | $3.19K | 0.00% | +240 | New |
| Lazard Asset Management LLC | 444 | $5.00K | 0.00% | +315+244.2% | Added |
| Group One Trading, L.P. | 394 | $5.24K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 610 | $8.12K | 0.00% | −34−5.3% | Reduced |
| Russell Investments Group, Ltd. | 719 | $9.57K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 834 | $11.1K | 0.00% | +432+107.5% | Added |
| Wells Fargo & Company | 951 | $12.7K | 0.00% | −300−24.0% | Reduced |
| SBI Securities Co., Ltd. | 1,416 | $18.8K | 0.00% | +1,416 | New |
| Point72 Asia (Singapore) Pte. Ltd. | 3,603 | $48.0K | 0.01% | +3,603 | New |
| Millennium Management LLC | 10,133 | $134.9K | 0.00% | −165,920−94.2% | Reduced |
| Northern Trust Corp | 11,170 | $148.7K | 0.00% | +11,170 | New |
| Cubist Systematic Strategies, LLC | 12,682 | $168.8K | 0.00% | +12,682 | New |
| Bridgeway Capital Management, LLC | 14,000 | $186.3K | 0.00% | 00.0% | Unchanged |
| Birchview Capital, LP | 22,000 | $292.8K | 0.24% | +22,000 | New |
| Marshall Wace, LLP | 24,958 | $332.2K | 0.00% | +24,958 | New |
| State Street Corp | 25,253 | $336.1K | 0.00% | +2,900+13.0% | Added |
| FMR LLC | 26,699 | $355.4K | 0.00% | +1,638+6.5% | Added |
| Morgan Stanley | 28,351 | $377.4K | 0.00% | +12,162+75.1% | Added |
| Staley Capital Advisers Inc | 50,000 | $665.5K | 0.03% | +10,000+25.0% | Added |
| Geode Capital Management, LLC | 54,744 | $728.8K | 0.00% | +8,024+17.2% | Added |
| BlackRock, Inc. | 60,846 | $809.9K | 0.00% | −108−0.2% | Reduced |
| Renaissance Technologies LLC | 67,140 | $893.6K | 0.00% | −594−0.9% | Reduced |
| Tang Capital Management LLC | 75,196 | $1.00M | 0.07% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 124,473 | $1.66M | 0.00% | −4,671−3.6% | Reduced |
| Vestal Point Capital, LP | 125,000 | $1.66M | 0.10% | +323+0.3% | Added |
| Vanguard Group Inc | 178,782 | $2.38M | 0.00% | −1,933−1.1% | Reduced |
| Bank of America Corp | 205,170 | $2.73M | 0.00% | +1,543+0.8% | Added |
| Citadel Advisors LLC | 267,353 | $3.56M | 0.00% | +6,873+2.6% | Added |
| Redmile Group, LLC | 441,701 | $5.88M | 0.41% | −10,569−2.3% | Reduced |
| EcoR1 Capital, LLC | 532,134 | $7.08M | 0.28% | +63,196+13.5% | Added |
| Centiva Capital, LP | 0 | $0 | 0.00% | −43,403−100.0% | Sold out |
| Global Retirement Partners, LLC | 0 | $0 | 0.00% | −750−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −100−100.0% | Sold out |